-

Bayer Signs Letter of Intent to Build New Distribution Center in Saxonburg, PA

New 220,000 square-foot Distribution Center to support ongoing growth of business

PITTSBURGH--(BUSINESS WIRE)--Bayer announced its plans to build a new 220,000 sq. ft. Distribution Center to support the ongoing growth of Bayer’s Radiology global business that supplies medical device products world-wide. A 10-year lease with optional extensions is being negotiated.

The facility, which will be operated and staffed by FedEx Supply Chain, is in response to growing product demand and steady growth of the business over the past few years. It allows for flexibility for future growth, including an additional expansion option of up to 80,000 sq. ft.

The Distribution Center will warehouse and distribute Bayer’s contrast injectors and sterile disposables kits used for the power injection of contrast-enhanced imaging procedures manufactured at Bayer’s local manufacturing operations in O’Hara, Saxonburg and Indianola. Its lease at the current distribution center, located in New Galilee, Pennsylvania is set to expire in March of 2022.

Included in the building design will be 28 Loading Docks, 1 drive in dock and 1 compactor, 60 tractor-trailer staging and administrative office spaces. It will be located within a mile of the Saxonburg manufacturing site.

Bayer’s Radiology products support imaging procedures in over 95% of the top 50 hospitals in the U.S. The products we make locally support Radiologists and health care providers to make diagnoses, and guide treatment decisions across health conditions and chronic diseases. Our portfolio includes medical devices, contrast media, Radiology software and equipment service across a broad range of imaging modalities, including CT, MR, PET, Interventional and Angiography.

“We are excited to build upon over 50 years of history serving our global customers from the Pittsburgh region, with the construction of this new Distribution Center,” stated Jeff Owoc, Bayer’s Senior Vice President and Global Head of Medical Device Operations. “The center will not only allow for future growth of our Radiology business but will enable us to continue to invest in the local Pittsburgh community.”

Additionally, the new center will feature updated warehouse and labor management systems as well as enhanced system connectivity aimed at improving transactional speed and accuracy. Coupled with automated conveyance systems, the new center will drive higher efficiencies and accuracy into the supply chain management process.

"FedEx Supply Chain is honored to be the supplier of choice for Bayer’s new distribution facility in Pittsburgh,” said Andy Smith, FedEx Supply Chain SVP and COO. "We look forward to managing and streamlining Bayer's supply chain needs so they can maintain focus on their customers and growing their business.”

Bayer has approximately 1,300 employees in Pittsburgh that support the Radiology business and other global operations.

Contacts

Jennifer May
Bayer U.S.
Jennifer.may@bayer.com
Mobile: (412) 656-8192

Bayer


Release Versions

Contacts

Jennifer May
Bayer U.S.
Jennifer.may@bayer.com
Mobile: (412) 656-8192

More News From Bayer

Bayer Accelerates Pharma Growth on High-Value Portfolio

SAN FRANCISCO--(BUSINESS WIRE)--On the occasion of the 44th J.P. Morgan Healthcare Conference in San Francisco, Bayer AG today unveiled the strategic focus for its Pharmaceuticals Division in 2026. Capitalizing on new launch momentum, the company will drive significant global regulatory expansions and market penetration across its pharmaceutical portfolio. High-value commercial products and an accelerating modality-rich pipeline across oncology, cardiology, neurology, and immunology have firmly...

Actress and Menopause Advocate Gabrielle Union-Wade Partners with Bayer in the Lynkuet® (elinzanetant) ‘Life Doesn’t Stop for a Hot Flash’ Campaign for Moderate to Severe Hot Flashes Due to Menopause

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced it has partnered with actress and menopause advocate Gabrielle Union-Wade on the ‘Life Doesn’t Stop for a Hot Flash’ campaign, which speaks to women with moderate to severe hot flashes due to menopause. The campaign encourages women to have an open and honest conversation with their healthcare provider about their hot flash experiences and learn about treatment options, including Lynkuet® (elinzanetant) 60mg capsules, a hormone-free prescri...

Bayer to Expand Into Molecular Imaging With Acquisition of Innovative Pan-Amyloid Radiotracers From Attralus

BERLIN & NAPLES, Fla.--(BUSINESS WIRE)--Bayer, a leading company in key areas of radiology and cardiology, and Attralus, Inc. (Attralus), a clinical stage biopharmaceutical company focused on developing medicines and diagnostics for systemic amyloidosis, today announced that the companies have entered into definitive agreements for Bayer to acquire AT-01 (124-Iodine-evuzamitide) and AT-05 (PAR-Peptide + technetium-99m), two investigational molecular imaging agents for the diagnosis of cardiac a...
Back to Newsroom